Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin

Home  /  National Uptake and Case Studies  /  Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin
CountryAgencyYear work was carried outLinkDetails of use
CroatiaAAZ2018LINKNational adaptation, added local information. National report with original report used for appraisal process (and decision) related to reimbursement of these technologies.
DenmarkDEFACTUM2018LINKNational adaptation, translation of the EUnetHTA assessment.
ItalyUCSC2018-National adaptation. Added local information.
NorwayNIPHNO2018-National adaptation. Made no changes to the EUnetHTA report.
SpainAETSAOngoing-The Spanish HTA body SESCS (Servicio de Evaluación del Servicio Canario de Salud) conducted a report regarding this topic at a national level a couple of years ago. The EUnetHTA report will be disseminated as an updated report to regional decision-makers.
SwitzerlandFOPH SNHTA - Swiss Network for Health Technology AssessmentOngoingLINKNational adaptation. Added local information.
United Kingdom (Scotland)SHTG-LINKNational adaptation. Made minor changes to information and added local information.
IrelandHIQA2018-Dissemination - A mini-HTA was undertaken and completed by the decision maker prior to OTJA08; OTJA08 was subsequently sent to them for information.
LithuaniaVASPVTCompleted in 2018-National adaptation. Translation and added local information.
PortugalINFARMED2018-19-National adaptation. Added local information.
United Kingdom (Wales)HTW2018-19-National adaptation. Added local information. Updated evidence.